With growing occurrence of zoonotic and food borne diseases in countries like MEA, is one of the factor influencing the demand of the attenuated live vaccines section in the region. The countries contained within the Central Europe and MEA region are highly reliant on the live stock trade as a resource of survival. Meat and milk are few of the general resources resultant of animal husbandry measures bring about in these regions.
Market Segmentation
The worldwide veterinary vaccines market is broadly segmented into vaccine type, disease indication, animal type, distribution channel and by country.
Forecast by market type
Based on the market type, the market is sub-segmented into inactivated vaccines, recombinant vaccines, DNA vaccines, attenuated live vaccines, toxoid vaccines and others. The attenuated live vaccines division was the biggest division as compare to other market type category. In 2016, the market was anticipated to generate nearly US$ 90 million and is estimated to reach above US$ 150 million at the end of forecast period 2026. The segment is likely to record a remarkable CAGR of 5.8% during the estimated period.
Forecast by disease indication
The worldwide market, based on disease indication includes new castle disease, foot and mouth disease, canine parvovirus, PPRS, avian influenza, brucellosis and others. The foot and mouth disease is likely to account for veterinary vaccines over 25% of revenues collected from the MEA region throughout the projected period.
Request and Download Sample Report@
https://www.persistencemarketresearch.com/samples/17014
Forecast by animal type
The overall veterinary vaccines market includes canine, companion animals, feline, avian, aquatic, livestock animals, porcine, bovine, equine, poultry and small ruminant.
Forecast by distribution channel
The veterinary vaccines are distributed through veterinary clinics, hospital pharmacies, private veterinary pharmacies and others.
Forecast by Country
The worldwide market is studied across the seven prominent regions
Kingdom of Saudi Arabia
United Arab Emirates
Jordan
Turkey
Egypt
Sudan
Rest of MEA
Among other regions, the UAE, Egypt, Turkey and Jordan are the main markets in the Middle East and African region. The MEA region at present is valued about US$ 267.3 Mn and is likely to grow at a steady rate by reaching nearly US$ 422.9 Mn in terms of value by the end of the assessment period 2026 as well as exhibiting a moderate 4.7% CAGR. The Jordan region is anticipated to lead the overall MEA market by recording a value share of US$88 Mn.
Key Market Players
The worldwide players in the veterinary vaccines market includes
Merial
Bioveta Inc.
Ceva
Bayer Healthcare AG
Zoetis
Intervac Pvt. Ltd.
Merck & Co, Inc.
Elanco
Buy Full Veterinary Anti-Infectives Market Report